← Back to headlines
Medtronic's Cardiovascular and Diabetes Divisions Show Double-Digit Growth in FQ4
Medtronic's cardiovascular and diabetes segments continued their strong performance in the fourth quarter, extending double-digit growth streaks.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
